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Intestinal Behcet’s disease may cause serious complications. Massive 
hemorrhage, fistulisation and intestinal perforation are encountered 
complications in approximately 50% of patients suffering from 
intestinal Behcet’s disease. The main sites of involvement are the 
terminal cecum and ileum. In patients with Behçet syndrome, CT is 
advocated for early detection of complications as well as for exclusion 
of other abdominal pathologic conditions but there is no specific exam. 
The report of histology in conjunction with the clinical history and the 
presence of oral ulcers, uveitis and suspected cutaneous lesions 
suggests the diagnosis. The optimal medical treatment of Behçet 
syndrome has not yet been well established. In rare cases surgery must 
be required to control the disease. We describe a case of ileal 
perforation with abscess in a 26-year-old female with Behcet's disease.  
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Introduction:- 
Behçet syndrome is a chronic, recurring, systemic disorder characterized by the histopathologic finding of non-
specific vasculitis in multiple organs. The International Study Group for Behçet's Disease proposed new diagnostic 
criteria in 1990 [1]. These criteria require the presence of oral ulcers plus any two of the following: genital ulcers, 
typical eye lesions, typical skin lesions, or a positive result of a pathergy test. Behçet syndrome involves the 
gastrointestinal tract in 10-50% of patients; such involvement results from vasculitis in the small vessels of the 
bowel wall, more frequently in the venules [2-3]. The main sites of involvement are the terminal ileum and cecum, 
but the upper gastrointestinal tract including the esophagus and, rarely, the stomach can be affected [4]. 
 
Case report: 
A 26-year-old woman presented to the Emergency Department of our hospital complaining of abdominal pain, fever 
and vomiting, in the previous 24h. His medical history revealed that 11 years ago he was diagnosed with Behcet’s 
Disease (BD). On examination, his vital signs were stable, but he presented an acute abdomen with fever. The 
laboratory results of the patient showed no anemia, an elevated leukocyte count and a high Creactive protein (Hb 
13.3g/dL, WBC 11500, Plat 112000. CRP 86mg/dl). We started the approach by asking an abdominal x-ray that 
showed a pneumoperitoneum. This way, an urgent CT scan revealed signs of pneumoperitoneum with abscess in the 
right iliac fossa (figure 1). An emergency laparotomy was performed for a suspected perforation in the GI tract. The 
right iliac fossa was filled with purulent fluid. During exploration, we found a perforation of the terminal ileum with 
stenosis (figure 2). We proceed to the resection of that segment of small bowel and a termino-terminal anastomosis. 
He was asymptomatic at the time of discharge from hospital. Histology revealed lacerations, areas of mucosal 
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necrosis, and perforations, and granulocytic inflammation, focal proliferation of capillaries. These aspects in favour 
of BD. 
 
 
 
Figure 1:-abscess in the right iliac fossa 
 
 
Figure 2:-perforation of the terminal ileum 
Discussion:- 
BD was first described in 1937 by the Turkish dermatologist, Hulus Behcet. Although seen worldwide, the highest 
prevalence is in Japan, the Middle East, and the Mediterranean region. It is uncommon in northern Europe and USA 
[5-6].The prevalence in Japan is 1 per 1000, in the Middle and Far East, 7 to 8 per 100,000, but 4 per 1,000,000 in 
the United States. The age at on set is usually between 20 and 30 years with a mean of 27 years, and men are more 
commonly affected, with 66% of case seen in males [5-7]. 
 
The etiology and pathogenesis are unknown, but theories include genetic factors, viral infection, environmental 
factors, and autoimmune mechanisms might play a role [8,9]. Also, there are some associations with human 
leukocyte antigens in Eastern countries [10]. In contrast to Reiter disease, in which the frequency of HLA-B27 is 
high, HLA-B5 and HLA-B51 are associated with Behçet syndrome. Although no organism is detectable, 
antistreptococcal antibodies have been found in some patients, and may be a more frequent history of streptococcal 
tonsillitis. Increased numbers of circulating immune complexes and elevated serum levels of tumor necrosis factor 
receptor, interferon gamma, and cytokines such as interleukin 1, interleukin 8, and antigens such as CD 8 and CD56 
may be involved in the pathogenesis [5-11]. 
 
The diagnosis is made clinically. The Interna-tional Study Group for Behcet's Disease proposed a standardized set of 
criteria in 1990, including recurrent oral ulceration and at least two other criteria: recurrent genital lesions, 
characteristic eye lesions, characteristic skin lesions, or a positive pathergy test. Patients who have only two of these 
criteria are considered to have an incomplete form of BD. Herpes simplex infection must be ruled out in patients 
with recurrent oral or genital ulcers. Referral to an ophthalmologist to identify ocular involvement is necessary, and 
cutaneous lesions should be biopsied [5-11,12]. 
 
BD is considered a relapsing and remitting vasculitis of the small-to-medium sized vessels [7-12]. Erythema 
nodosum-like lesions of BD are characte-rized by panniculitis, usually with a lobular or mixed septal pattern, with 
variable numbers of neutrophils, lymphocytes, and histiocytes as well as variable numbers of necrotic adipocytes. 
Vasculitis is noted in most erythema nodosum-like lesions in BD [13]. 
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Central nervous system manifestations include cerebellar ataxia,meningoencephalitis, benign intracranial 
hypertension, cerebrovascular thrombosis, and vasculitis. 
 
Pulmonary arterial aneurysms, pulmonary hypertension, pulmonary embolism, pericarditis and myocardial 
infarction are infrequent. Some authors have reported intestinal BD to be associated with generalized myositis. 
 
The main digestive tract symptoms are abdominal pain, fever, hematochezia, and diarrhea. Lesions may occur in any 
part of the digestive tract but are especially prominent in the ileocecal region. However, multiple esophageal and 
gastroduodenal ulcers may also be seen. The ulcers are discrete and relatively oval in shape rather than longitudinal; 
no cobblestone features are seen [5-11,14-15]. The appearance of central ringlike collections of barium 
superimposed on large nodular lesions in the terminal ileum has been reported to be a specific manifestation of 
intestinal BD [16]. 
 
Computed tomography (CT) has advantages in demonstrating bowel wall thickening and lesions in the extraluminal 
space. Therefore, in patients with Behçet syndrome, CT is advocated for early detection of complications as well as 
for exclusion of other abdominal pathologic conditions [17-18]. Furthermore, CT might allow prediction of the 
possibility of complications [17]. There is no specific exam. The report of histology in conjunction with the clinical 
history and the presence of oral ulcers, uveitis and suspected cutaneous lesions suggests the diagnosis. The 
differential diagnosis should include all the intestinal inflammatory diseases. 
 
The optimal medical treatment of Bechet syndrome has not yet been well established. The natural history of 
exacerbation and remission makes evaluation of therapy difficult [19]. Corticosteroids are the mainstay of medical 
therapy in Behçet syndrome. Other medical treatments such as azathioprine, colchicine, dapsone, levamisole, 
thalidomide, and immunosuppressive therapies have been advocated [18,20]. For mucocutaneous lesions, steroids, 
colchicine and dapsone can be used. For more Severe  mucocutaneous disease or systemic lesions, other 
immunosuppressants or interferon alfa can be added. There has also been a report of treating ileocecal ulceration 
using hyperbaric oxygen therapy in patient who was unresponsive to steroid therapy. The authors suggested that 
improved oxygenation and circulation to the mucosa may enhance fibroblast proliferation and lead to accelerated 
healing of the ulcer [21].  In rare cases surgery must be required to control the disease. 
 
Kariv et al  [22] reviewed 83 cases of systemic vasculitis presenting as a tumor-like lesion. The locations varied 
considerably and they found that surgery was sometimes performed unnecessarily because the diagnosis of 
vasculitis had not been considered. 
 
Conclusion:- 
Patients in whom medical therapy has been unsuccessful or who have extensive disease or complications such as 
perforation should be considered for surgery. This possibility should be included in the differential diagnosis of 
abdominal pain in such patient. 
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